drugset / Trial / NCT01842633

Clinical Study to Evaluate Efficacy of New Paracetamol Formulation Compared to Ibuprofen in Headache

NCT01842633

Phase 3 Terminated 365 enrolled GlaxoSmithKline
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this multi-center study is to assess the efficacy of headache relief of new paracetamol/caffeine formulation compared to placebo and ibuprofen in episodic tension-type headache (ETTH).

Timeline

Start
2013-04-01
Primary completion
2015-03-31
Completion
2015-03-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetaminophen Small molecule 500 mg
Subject Caffeine Small molecule 65 mg
Comparator Ibuprofen Small molecule 200 mg

Indications

No indication recorded.